Lowest Price Guaranteed
Slides
243
Last Updated
March 2025
View Count
9407
The global clinical data analytics market size is estimated to be valued at USD 6.31 billion in 2025 and is expected to reach USD 15.33 billion by 2035, representing a CAGR of 9.3% over the forecast period.
 |
To learn more about this report, request a free sample copy
Clinical data analytics refers to the collection and analysis of medical data to improve healthcare outcomes. The process involves advanced analytics tools, such as predictive analysis and big data analytics tools to capture clinical data in real time. Notably, with rising trend of personalized medicine the demand for clinical data analytics tools and technologies has skyrocketed. These clinical data analytics tools play a significant role in understanding disease insight and designing treatment plans based on the information collected using these advanced technologies. In addition to disease diagnosis and treatment, clinical data analytics has been widely adopted in clinical research for data collection, analysis and storage to facilitate the drug discovery, development and approval process.
Additionally, the increasing demand for advanced clinical data analytics solutions to extract data from real-world and offer valuable insights to enhance customized medical treatments are the key clinical data analytics market growth factors. It is important to highlight here that the USFDA has supported the use of clinical analytics tools, digital health technologies and also adopted Clinical Data Interchange Standards Consortium standards to maintain robust interoperability, accuracy and consistency of clinical data. Furthermore, digital health technologies have been adopted for remote data collection, risk management and compliance with the regulatory guidelines.
Considering the growing acceptance of clinical data analysis across applications, several stakeholders are focusing on providing advanced software and technologies that aid in management, collection and extraction of patient health data. For instance, in December 2024, STI Clinical announced the release of its latest software V4.4 integrated in STISIM Drive® which is specifically designed to enhance clinical assessment and rehabilitation abilities. Similarly, a lot of industry players are seeking technological innovations, such as AI integration and big data in healthcare industry for enhancing clinical data evaluation. Driven by the growing efforts by industrial leaders, we believe that the clinical data analytics market will grow at a substantial pace during the forecast period.
The market research report presents an in-depth analysis of various industrial players that are involved in global clinical data analytics industry, across different segments, as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Market Size 2035 | $15.33 Billion | |
| CAGR (Till 2035) | 9.3% | |
| Type of Deployment |
|
|
| Type of Solution |
|
|
| Type of Application |
|
|
| End Users |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the clinical data analytics market report was to understand the future of clinical data analytics in healthcare, estimate the current size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The market analysis also features the likely distribution of the current and forecasted opportunity within the market distributed across various segments, such as type of deployment (cloud-based and on-premise), type of solution (platforms (cloud-based and on-premise) and services (consulting services, integration and implementation services, and support and maintenance services)), type of application (clinical decision support, clinical trials, regulatory compliance and other applications), end user (pharmaceutical and biotechnology companies, healthcare providers, payers and other end-users), geographical region (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
The global market is segmented across different types of deployment, such as cloud-based and on-premises. According to our market study, presently cloud-based deployment holds majority of the clinical data analytics market share. Cloud-based deployment offer easy scalability, faster integration and seamless data sharing in real-time. Furthermore, cloud-based deployment reduce initial investment, remote accessibility and allow resources allocation more effectively. It is important to highlight here that cloud-based deployment can easily be integrated with advanced clinical data analytical tools, which is essential for predictive analytics and clinical studies. Driven by the increasing preferences for cloud-based deployment, this segment will continue to grow at a higher CAGR during the forecast period.
On the basis of the type of solution, the global clinical data analytics market is segmented into platforms (cloud-based and on-premise) and services (consulting services, integration and implementation services and support and maintenance services). According to our projection, platforms currently holds the highest share of the market driven by the growing adoption of smart cloud-based technologies and digital solutions for analyzing clinical data. IQVIA launched its clinical data analytics platform called CDAS in June 2021. Driven by the ongoing trend, this segment will continue to remain dominant and is likely to grow at a higher CAGR during the forecast period.
Over the years, the rise in the services sector has also been observed. The companies are making strategic initiatives in order to expand their service portfolio. In March 2024, Florida Cancer Specialists & Research Institute, LLC (FCS) launched a company, Vita Nova Insights, that will offer real time evidence, analytics support and platform solutions which will aid in developing cancer therapeutics and improve the patient outcomes. As stated by Nathan H. Walcker (Chief Executive Officer, FCS), “Formally organizing our efforts with Vita Nova Insights cements our deep commitment to oncology research and further reflects our collective ability to generate real-world evidence that truly enables the discovery, development, and optimization of new therapeutic products. This platform is unmatched-harmonizing analytics talent, deep and clinically rich longitudinal datasets, and a market-leading independent community oncology group. There's nothing out there like it.”
Based on the type of application, the global clinical data analytics market size is segmented into clinical decision support, clinical trials, regulatory compliance and other applications. According to our projection, currently clinical trials accounts for the highest share of the market. This can be attributed to the fact that clinical data analytics tools have been widely adopted to analyze vast amount of data generated for drug approval. However, in the long run, clinical decision support segment is likely to grow at a higher CAGR during the forecast period. This substantial growth is due to the growing usage of clinical data analytics solutions for tailoring treatment plans to meet individual patients requirement. In addition, clinical data analytics solutions are integrated with artificial intelligence that allow researchers in gaining deep insight about diseases.
On the basis of end user, the market for clinical data analytics is distributed across pharmaceutical and biotechnology companies, healthcare providers, payers and other end-users. According to our market analysis, pharmaceutical and biotechnology companies hold the highest share (nearly 40%) of the market and the trend is likely to remain unchanged during the forecast period. Pharmaceutical and biotechnology are leveraging advanced clinical data analytical solutions to optimize data collection, trial designing, recruitment processes and managing workflow. Furthermore, the growing usage of clinical data analytics for drug candidates pricing, drug approval documentation and pricing strategy optimization has further fueled the growth of this segment. Notably, with increasing adoption of clinical data analytics tools for clinical trials and drug development by pharmaceutical companies, this segment will continue to grow at a higher CAGR during the forecast period.
The global clinical data analytics market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, North America dominates the market with a share of 54%. This dominance is due to the widespread adoption of advanced analytical tools by pharmaceutical companies and clinicians established in this region. Additionally, the shift towards personalized medicine and growing preferences for patient-centric treatment has further bolstered the demand for clinical data analytics solutions in this region.
However, it is important to highlight here that Europe is expected to register a higher CAGR during the forecast period. In Europe, the market for clinical analytics has gained tractions driven by the government initiatives to advance healthcare infrastructure. Further, the high adoption of advanced technologies specifically in pathology and radiology field for disease diagnosis has contributed to the growth of market during the upcoming years in this region.
The “Clinical Data Analytics Market: Industry Trends and Global Forecast, till 2035” market report features an extensive study of the current market landscape, market size and future opportunity within the clinical data analytics industry, during the given forecast period. The market report highlights the efforts of several stakeholders involved in this rapidly emerging segment of the service providers industry. Key takeaways of the research report are briefly discussed below.
Currently, the market landscape of clinical data analytics is highly competitive, featuring a wide array of well-established and new entrants. These industrial players are offering wide range of clinical data management and data analytics services that helps in streamlining information and reduce human errors. In order to leverage competitive edge, several market players are taking strategic initiatives such as collaborations, acquisitions and latest product launches to strength their market positions. For instance, in September 2024, Medidata partnered with European Organization for Research and Treatment of Cancer to enhance clinical data management in oncological research. This strategic partnership enables the European Organization for Research and Treatment to improve patient access and optimize clinical trials participations by leveraging single clinical data platform for massive data handling. As more market players enter into the industry for innovations, we believe the clinical data analytics market will remain competitive during the forecast period.
The market for clinical data analytics is witnessing an upward trajectory driven by the rising adoption of digital healthcare solutions and analytics technologies for data assimilation and evaluation. Furthermore, the heightened demand for personalized medicine to treat broad range of chronic conditions has bolstered the requirement of advanced clinical data analytics tools. Moreover, the higher adoption rate of predictive analytics tools for actual time data insights through healthcare services has further fueled the demand for clinical data analytics tools.
Some of the major challenges that impede clinical data analytics market growth include data protection and technological complexities. It is important to highlight here that healthcare systems has unstructured records which create challenges in analysis data through clinical data analytics tools. Furthermore, data privacy concerns may pose a significant barrier for widespread adoption of these technologies on a large scale. In addition, stringent guidelines associated with Health Insurance Portability and Accountability Act (HIPAA) to ensure data privacy and security may create challenges for the industrial players.
Some of the notable market trends that are anticipated to drive the market include integration of AI technologies, machine learning and adoption of decentralized clinical trials. Notably, the integration of artificial intelligence in clinical data analytics offer real-time insight and reduce dependency on skilled personnel in data management. Additionally, the increasing shift towards decentralized clinical trials to conduct research remotely and make clinical studies more accessible has further increased the demand for advanced clinical data analytics tools. Moreover, the growing emphasis on cybersecurity to enhance data privacy has further created opportunities for industrial players to develop advanced AI-powered clinical data analytic solutions.
According to our projection, the global market for clinical data analytics platforms and services is currently valued at USD 6.31 billion and is poised to reach at USD 15.33 billion by 2035. Driven by the ongoing demand of advanced clinical analytic tools for patient healthcare record analysis and clinical studies, this market is estimated to grow at a CAGR of 9.3% during the forecast period. It is worth noting here that several industrial players are forging strategic partnerships aiming to enhance usage of clinical data analytics tools and platforms for streamlining clinical studies. For instance, in December 2024, Medidata renewed its partnership with ClinChoice (a global contract research organization). Under this partnership, ClinChoice will harness Medidata Clinical Data Studio platform for data collection, study and supply management, aiming to enhance data management experience.
Driven by the ongoing partnerships between industrial players, we believe that the market will remain competitive and is likely to grow at a substantial rate during the forecast period. This market report also provides regional analysis of the clinical data analytics market, including key regional trends driving the market.
Examples of key players engaged in this domain (which have also been captured in this report) Allscripts Healthcare, Accenture, Cerner, Cognizant Technology Solutions, Flatiron Health, Health Catalyst, McKesson, Medidata Solutions, Philips Healthcare, PAREXEL International, Inspirata, IQVIA, IBM, Koninklijke Philips, Oracle, Optum, Roche, SAS Institute, Tempus AI and Veeva Systems. This market report includes an easily searchable excel database of all the companies focusing on the development of clinical data analytics solutions.
Several recent developments have taken place in the clinical data analytics industry. We have outlined some of these recent initiatives below.